tility in different vessels, although of critical importance in health and disease, involves multiple factors of the signal-transduction cascade, the interrelations of which are poorly understood (15) . In addition to mobilization of inositol 1,4,5-trisphosphate [Ins(1,4,5)P 3 ] via G proteins and phospholipase C-␤ (PLC), noradrenergic stimulation of ␣ 1 -adrenergic receptors (AR) is associated with synthesis of diacylglycerol (DAG), which results in activation of protein kinase C (PKC) (29) . Members of the PKC family of isoenzymes play a key regulatory role in a variety of cell functions including cell growth and differentiation, gene expression, membrane function, and so forth (29) . In cerebral and other blood vessels, PKC has been shown to play a dual role in the regulation of tone. By negative feedback, PKC may inhibit PLC, thereby attenuating the agonist-induced increases in Ins(1,4,5)P 3 , intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ), and contraction (2, 27) . In addition, PKC activation per se can increase vascular tone (6, 31, 34) . PKC may also modulate vascular smooth muscle Ca 2ϩ sensitivity to ␣-adrenergic and other agonists (28) . Nonetheless, the role of PKC-mediated mechanisms in cerebral vessels and how these change with development from fetus to adult is unclear.
To test the hypothesis that in fetal cerebral arteries, the dual role of PKC activation in modulating norepinephrine (NE)-induced stimulation of Ins(1,4,5)P 3 , [Ca 2ϩ ] i , and [Ca 2ϩ ] i -independent increases in vascular tone differs significantly from that of the adult, we performed the following studies. In fetal and adult cerebral arteries, we quantified PKC in both absolute amounts and as percent membrane bound (active form) under basal conditions and after PKC stimulation or inhibition. We also measured relative levels of the several PKC isoforms in adult and fetal cerebral arteries. We also quantified Ins(1,4,5)P 3 levels in response to PKC stimulation or inhibition. In addition, in middle cerebral arteries, we simultaneously measured vascular tension and [Ca 2ϩ ] i responses to NE after PKC activation or inhibition.
METHODS

Experimental animals and tissues.
For these studies, we used cerebral arteries from near-term fetal (ϳ140 days) and nonpregnant adult sheep (Յ2 yr) obtained from Nebeker Ranch (Lancaster, CA). The ewes were anesthetized and killed with 100 mg/kg intravenous pentobarbital sodium, after which we obtained anterior, middle, and posterior cerebral arteries or, in the case of tension and [Ca 2ϩ ] i measurements, the main branch middle cerebral artery (MCA). For comparison with an extracranial vessel, for some studies, we also obtained segments of common carotid artery (CCA). We have shown that this method of death has no significant effect on vessel reactivity compared with the use of other anesthetic agents (23) . Studies were performed in isolated vessels cleaned of adipose and connective tissue, as previously described (23, 24) . To avoid the complications of endothelial-mediated effects, we removed the endothelium by carefully inserting a small wire three times (23, 24) .
The vessels were used immediately for the experiments. In arteries used for response to a given agonist (e.g., NE or phenylephrine) and PKC agonist or antagonist, we added the PKC agonist/antagonist for 10 min before administration of NE. Unless otherwise noted, all chemicals were obtained from Sigma Chemical (St. Louis, MO).
Measurement of PKC. Arteries (ϳ30 mg wet wt) were placed in ice-cold 50 mM Tris ⅐ HCl (pH 7.4) and exposed to various treatments according to the protocol. The reaction was terminated by freezing in liquid N 2 , and the tissues were homogenized in 2 ml Tris ⅐ HCl buffer containing (in mM) 50 Tris ⅐ HCl, 5 EDTA, 10 EGTA, 10 benzamidine, 0.3% ␤-mecaptoethanol, and 50 g/ml phenylmethylsulfonyl fluoride (pH 7.5) with a glass grinder. The homogenate was centrifuged at 100,000 g for 30 min. Assay of the supernatant was defined as cytoplasmic PKC activity. Membrane-bound PKC activity was extracted from the pellet by resuspension in 20 mM Tris ⅐ HCl (pH 7.4) containing 1% Triton X-100 and assayed in the supernatant after recentrifugation. Proteins in both the membrane and cytosolic fractions were measured by the Bradford method (4). PKC activity was determined by an assay (Amersham) based on PKC-catalyzed transfer of the ␥-phosphate group of ATP to a PKC-specific peptide. Samples were incubated with a PKC assay mixture and 32 P-labeled ATP for 20 min at 37°C. Aliquots of the mixture were spotted on paper discs, washed two times with 75 mM orthophosphoric acid, and the discs were counted for 2 min in 10 ml scintillation fluid. Data were expressed as picomoles of PO 4 incorporated per minute per milligram of protein. The intraand interassay coefficients of variation for the assay were 4% and 3%, respectively.
We first measured basal total PKC activity (i.e., both the membrane-bound and cytosolic fractions). Then to examine the response to stimulation, arteries were prepared as above and equilibrated in media bubbled with 95% O 2 -5% CO 2 for 0.5 h. Tissue was then treated with phorbol 12,13-dibutyrate (PDBu; 10 Ϫ7 to 10 Ϫ4 M) for 10 min [in some cases we repeated the study with the more selective PKC activator indolactam V (Indo), 10 Ϫ7 to 10 Ϫ6 M]. The reaction was terminated by quickly freezing the tissue in liquid N 2 , and it was analyzed for PKC activity. To examine the NE dose-PKC response, arteries were prepared and pretreated 30 min before the study with 10 Ϫ7 M yohimbine to block ␣ 2 -ARs and 10 Ϫ6 M propranolol to block ␤-ARs. First, we determined the NE (10 Ϫ7 to 10 Ϫ4 M) dose-PKC response relationship, rapidly freezing the tissue and quantifying PKC after a given NE dose. We also examined the response to NE plus 10 Ϫ4 M PDBu or 10 Ϫ6 M Indo concentration (which we have shown gives peak response). To examine PKC responses in the presence of the PKC inhibitors staurosporine (Sta; 10 Ϫ7 M) or calphostin C (Cal; 10 Ϫ7 M) administered 10 min before the study, we repeated the NE (10 Ϫ7 to 10 Ϫ4 M) stimulation in the absence or presence of these agents.
Immunoblotting of PKC isoenzymes. Fetal and adult sheep cerebral arteries were first isolated, cleaned in the Krebs buffer, and then frozen in liquid nitrogen. Frozen samples were homogenized in liquid N 2 with a porcelain mortar and pestle. Homogenized samples then were incubated for 10 min in the lysing buffer [20 mM Tris ⅐ HCl, 1 mM EDTA, 1 ug/ml pepstatin, 1 ug/ml leupeptin, 1 ug/ml aprotinin, 0.1 mg/ml benzamidine, and 8 ug/ml calpain inhibitors I and II (pH 7.4)]. Nuclei and debris were pelleted by centrifugation at 1,000 g for 20 min. The whole cell lysate was then stored at Ϫ20°C. The pellet (membrane-bound protein) was resuspended in the lysing buffer, sonicated, and stored at Ϫ20°C.
A precast 10% polyacrylamide gel (Bio-Rad Laboratories, Hercules, CA) was loaded with 40-80 ug of purified protein mixed with an equal volume of 2ϫ electrophoresis sample buffer per lane. The samples were boiled for 5 min before loading and electrophoresed at 100 V for 1.5 h. A Mini Trans-Blot Electrophoretic Transfer Cell system (Bio-Rad Laboratories) was used to transfer proteins from the gel to a nitrocellulose membrane at 100 V for 1 h.
Blocking for nonspecific binding was performed by incubating the membrane overnight in blotting solution [5% nonfat milk in 1ϫ Tris-buffered saline (TBS) with 0.1% Tween 20] at 4°C. Then, we performed a 3-h incubation of diluted (1:200) primary antibody (PKC-␣, -␤ I , -␤ II , -␥, -⑀, etc., and ␣-tubulin as an internal control and the ␣-tubulin blocking peptide as a negative control; Santa Cruz Biotechnology, Santa Cruz, CA) in blotting solution at room temperature (22°C) followed by a wash (3 times for 10 min each with TBS, 0.1% Tween 20, and once for 5 min with TBS). For each isoform, the controls were as follows: Jurkat whole cell lysate (25 g/lane), PKC-␣, -␤I, -␤II, -␦, -, -; rat heart (25 g/lane), PKC-⑀; rat brain, PKC-and -; 3611-RF whole cell lysate (25 g/lane), PKC-␥ and -(Santa Cruz Biotechnology). These several antibodies have been shown to react with the specific PKC isoforms in a number of mammalian tissues. Incubation with horseradish peroxidase and a conjugated secondary antibody (Santa Cruz Biotechnology) for 1 h at room temperature at a 1:2,000 dilution in blotting solution was followed by a wash (3 times for 10 min each with TBS, 0.1% Tween 20, and once for 5 min with TBS). The membrane was incubated in chemiluminescence luminol reagent (Santa Cruz Biotechnology) for 1 min, and the protein band was detected by using Hyperfilm (Amersham Life Science, Arlington Heights, IL). In an attempt to maintain the immunoblotting labeling conditions constant, we used the same titer of polyclonal anti-PKC antibodies and the same protein concentration in all samples. The polyclonal antibody titers and protein concentrations were chosen on the basis of preliminary experiments to determine optimal conditions on the linear portion of the titration curve.
Ins (1, 4, 5 )P 3 quantification. From each fetal and adult animal, cleaned cerebral arteries were cut into segments weighing ϳ20 mg (wet wt) and placed in Krebs buffer and bubbled with 95% O 2 -5% CO 2 for 0.5 h. The Krebs buffer contained (in mM) 115.2 NaCl, 4.7 KCl, 1.2 MgSO 4 , 1.2 KH 2 PO 4 , 22.1 NaHCO 3 , 7.9 Dextrose, 0.03 EDTA, and 1.8 CaCl 2 (pH 7.4). We exposed the arteries to various treatments outlined in Measurement of PKC (PKC stimulation or inhibition) at 37°C according to the protocol. The reactions to the various treatments were terminated by freezing in liquid N 2 , and frozen samples were homogenized in 2 ml iced 16% trichloracetic acid with a glass grinder. The homogenate was centrifuged for 30 min at 1,500 g, the supernatant transferred, and the pellet resuspended in 1 M NaOH for protein measurements (4 ] i . We cut the fetal or adult MCAs into rings of 2 mm in length, mounted them on two Tungsten wires (0.13-mm diameter; A-M Systems, Carlsborg, WA), attaching one wire to an isometric force transducer (Kent Scientific, Litchfield, CT) and the other to a post attached to a micrometer used to vary resting tension in a 5-ml tissue bath mounted on a Jasco CAF-110 Intracellular Ca 2ϩ Analyzer (Jasco, Easton, MD). The tension value along with vessel inside diameter, wall thickness, length, and potassium-induced force enabled calculation of force per unit cross-sectional area, as previously described (32) . MCA rings were equilibrated under 0.3-g tension at 25°C for 40 min before loading with the acetoxymethyl ester of fura 2 (fura 2-AM; Molecular Probes, Eugene, OR), a fluorescent Ca 2ϩ indicator. Mean cytoplasmic [Ca 2ϩ ] i depends on where fura 2 is located (9). Fura 2 fluorescence and force were measured simultaneously at 38°C, as previously described by Long et al. (22) . As we have noted, although some investigators may prefer the transformation of fluorescence to [Ca 2ϩ ] i , in tissues such as cerebral arteries, the presentation of the ratio is less ambiguous. During all contractility experiments, we continuously digitized, normalized, and recorded contractile tensions and the fluorescence ratio (R 340/380 ) using an online computer. For all vessels, we evaluated the contractile response for tension and fluorescence ratio by measuring the maximum peak height, and expressing it as percent K max (a measure of "efficacy") and calculated pD 2 (the negative logarithm of the EC 50 or halfmaximal concentration for NE and an index of tissue "sensitivity" or "potency") (22) . As previously reported, although in absolute terms, the maximal values of fetal MCA K ϩ -and NE-induced tension are 20-30% less than those of the adult (22, 32) , expressing these in terms of K max helps to normalize the data and does not alter the interpretation of the results.
In arteries used for response to PKC stimulation (PDBu or Indo) or inhibition (Sta or Cal) after the NE dose response, we added the pharmacological agent and repeated the NE dose response. In studies with PKC stimulation, we examined this in two ways. After the unblocked NE-induced response, we repeated the dose response after PKC stimulation. Then, in a second study, we administered 10 Ϫ5 M NE to achieve nearmaximal response, at which time we gave PDBu in increasing doses to follow the [Ca 2ϩ ] i and tension-inhibition response. In a separate series of studies, we examined PDBuand Indo-induced vascular contractility per se.
Role ] i and tension in response to NE or PKC stimulation after vessels had been exposed to calcium-free (Ͻ10 Ϫ8 M Ca 2ϩ with 5 ϫ 10 Ϫ4 M EGTA to chelate Ca 2ϩ ) Krebs buffer for 2 min (n ϭ 4). Again, we evaluated the contractile response of tension and fluorescence ratio by measuring the maximum peak height and expressing it as percent K max (22) .
Statistical analysis. All values were calculated as means Ϯ SE. In all cases, n values refer to the number of vessels (which corresponds to the number of animals and is included in Table 1 ) for a particular study. Because of the nature of these studies, several statistical tests were used to test for significant differences. For testing differences between two groups, a simple unpaired Student's t-test was used. For multiple comparisons, one-and two-way ANOVA (vessel, age) coupled with Duncan's multiple-range test was used. When appropriate, we used ANOVA with repeated measures. A P value of Ͻ0.05 was considered significant. Table 1 gives the basal levels of PKC activity in adult and fetal cerebral arteries, both as total absolute value (cytosolic ϩ membrane bound; pmol ⅐ min Ϫ1 ⅐ mg protein Ϫ1 ) and as the percent membrane bound (i.e., the active form). PKC values in both age groups were similar, whether expressed as total PKC (adult and fetal were 204 Ϯ 17 and 239 Ϯ 31, respectively) or as percent membrane bound (32 Ϯ 4% and 38 Ϯ 4%, respectively; Table 1 ). By way of comparison, in contrast to these values that showed no significant difference between adult and fetus, in CCA, the values were significantly different; namely, total PKC for adult and fetal CCA were 532 Ϯ 32 and 215 Ϯ 13, respectively (P Ͻ 0.01; n ϭ 12), whereas the percent membrane-bound values were 28 Ϯ 2% and 52 Ϯ 4%, respectively (P Ͻ 0.01). PKC isoenzymes. To determine the extent to which the relative expression of different PKC isoenzymes may account for differences in responses, in fetal and adult cerebral arteries, we measured these isoforms under basal conditions. Figure 1 illustrates the PKC isoenzyme profile in whole cell extracts that were subjected to Western analysis using enhanced chemiluminescence detection, as described in METHODS. As seen in Fig. 1 , adult ovine cerebral arteries appear to express relatively abundant amounts of both the "classic" or "group A" isoforms [PKC-␣ (2ϩ), -␤ I (2ϩ), and -␤ II (1ϩ)] and "novel" or "class B" isoforms [PKC-⑀ (3ϩ) and -(1ϩ)]. In contrast, whereas in fetal cerebral arteries, immunoblotting shows PKC-␣ (2ϩ), -␤ I (2ϩ), -␤ II (1ϩ), and -(2ϩ), these vessels demonstrate low levels of the PKC-⑀ (1ϩ) isoform. Immunoblots of ␣-tubulin are shown as an internal control.
RESULTS
Basal PKC values.
PKC and its activation. Table 1 also presents adult and fetal cerebral artery PKC activity as percent membrane bound in response to several treatments. For instance, in response to 10 Ϫ4 M NE, whereas total PKC did not change significantly from control, the percent membrane bound increased to 44 Ϯ 5% and 51 Ϯ 6% for adult and fetus, respectively (P Ͻ 0.01 for each). In adult and fetal cerebral arteries, 10 Ϫ4 M PDBu increased PKC activity to 50 Ϯ 6% and 66 Ϯ 8%, respectively (P Ͻ 0.01 for each). , respectively (P Ͻ 0.01 for each; n ϭ 5).
By way of comparison, in adult CCA, although 10
Ϫ4
M PDBu stimulation increased PKC activity 68% (to 47 Ϯ 5% from 28 Ϯ 2%; n ϭ 15; P Ͻ 0.01), it had no effect on the fetal vessel (51 Ϯ 6%, n ϭ 5). Again, with PKC inhibition by 10 Ϫ6 M Sta, the total PKC value of adult and fetal CCA fell 60-80% to 205 Ϯ 30 and 40 Ϯ 8 pmol⅐ min Ϫ1 ⅐ mg protein
Ϫ1
, respectively from control (P Ͻ 0.01 for each; n ϭ 5).
PKC-Ins(1,4,5)P 3 interaction. To examine the role of PKC activation on the NE-induced Ins(1,4,5)P 3 increase, we measured this response under several conditions. As shown in Fig. 2A , in cerebral arteries of the adult, NE stimulation resulted in a significant dosedependent 104% increase in Ins(1,4,5)P 3 concentration from 23 Ϯ 4 to 47 Ϯ 5 pmol/mg protein (n ϭ 7 each point; pD 2 ϭ 5.2 Ϯ 0.1). The response to the selective ␣ 1 -AR agonist phenylephrine was similar. With 10 Ϫ4 M PDBu pretreatment to stimulate PKC activity, Ins(1,4,5)P 3 concentrations were below basal control values, e.g., 8-12 pmol/mg protein, and failed to respond to NE (n ϭ 5; Fig. 2A) . In a similar manner after pretreatment with 10 Ϫ6 M Indo, Ins(1,4,5)P 3 did not respond to NE stimulation. In contrast, with 10 Ϫ7 M Sta pretreatment to inhibit PKC activity, NE stimulation resulted in a robust increase of Ins(1,4,5)P 3 concentration as NE dose increased (for instance, to 53 Ϯ 2 pmol/mg protein at 3 ϫ 10 Ϫ6 M NE), with an increase of pD 2 to 6.1 Ϯ 0.1 (n ϭ 5; Fig. 2A) . In a similar manner, pretreatment with 10 Ϫ7 M Cal resulted in increased sensitivity of Ins(1,4,5)P 3 to NE stimulation that was not significantly different from that seen in the presence of Sta.
In contrast, fetal cerebral arteries showed a different pattern of response (Fig. 2B) . Unopposed NE stimulation resulted in a significant dose-dependent 45% increase in Ins(1,4,5)P 3 concentration (from 29 Ϯ 3 to 42 Ϯ 5 pmol/mg protein; pD 2 ϭ 5.4 Ϯ 0.1; n ϭ 5). Again, with 10 Ϫ4 M PDBu pretreatment, Ins(1,4,5)P 3 concentrations were below the basal control value, e.g., [8] [9] [10] [11] [12] pmol/mg protein, with no increase in response to NE. In contrast to the adult vessels, however, 10 Ϫ7 M Sta pretreatment followed by NE stimulation resulted in an increase of Ins(1,4,5)P 3 concentration not significantly different from that of NE alone (n ϭ 5 each point; Fig. 2B ).
By way of comparison with an extracranial vessel, in adult CCA, Ins(1,4,5)P 3 showed a dose-dependent rise in response to increasing NE concentration from a basal value of 20 Ϯ 2 to 37 Ϯ 3 pmol/mg protein (85% increase at 10 Ϫ4 M; n ϭ 6 for each point; pD 2 ϭ 5.2 Ϯ 0.1). As with the cerebral arteries, when adult CCA was pretreated with 10 Ϫ4 M PDBu, basal Ins(1,4,5)P 3 decreased to 12 Ϯ 2 pmol/mg protein and failed to increase in response to 10 Ϫ4 M NE. As with the adult cerebral arteries, when adult CCA was pretreated with 10 Ϫ7 M Sta, Ins(1,4,5)P 3 increased 42% above control to 34 Ϯ 3 pmol/mg protein at 3 ϫ 10 Ϫ6 M NE (pD 2 ϭ 5.6 Ϯ 0.1; n ϭ 5). In contrast to the cerebral arteries and adult CCA, fetal CCA failed to show a significant increase in Ins(1,4,5)P 3 in response to NE stimulation from its basal value of 21 Ϯ 2 pmol/mg protein. However, in a manner similar to the other vessels, with 10 Ϫ4 M PDBu pretreatment, Ins(1,4,5)P 3 concentrations were below basal values and failed to respond to NE. In contrast to the cerebral arteries, after 10 Ϫ7 M Sta pretreatment of the fetal CCA, NE stimulation resulted in a robust elevation of Ins(1,4,5)P 3 concentration to 45 Ϯ 6 pmol/mg protein at 3 ϫ 10 Ϫ6 M NE (n ϭ 5; pD 2 ϭ 5.8 Ϯ 0.1), suggesting release of PKCmediated inhibition.
PKC- [Ca 2ϩ ] i interaction. To examine the effect of PKC activation on NE-mediated increase in [Ca 2ϩ ] i and tension, we quantified these responses under several conditions. Figure 3A shows tension as percent K max in adult MCAs in response to increasing NE concentration (n ϭ 8). The figure also shows the effects of 10
Ϫ7
, 10 Ϫ6 , and 10 Ϫ4 M PDBu (e.g., PKC stimulation) on inhibiting the contractile response (n ϭ 4 ] i responses to NE in the presence of 10 Ϫ6 M Indo (n ϭ 3) were similar to those of PDBu. Figure 3C shows the fetal MCA tension as percent K max in response to increasing NE concentrations under control conditions and in the presence of 10 Ϫ7 , 10 Ϫ6 , and 10 Ϫ4 M PDBu (n ϭ 4). As is evident, whereas both 10 Ϫ6 and 10 Ϫ7 M PDBu attenuated the response, 10 Ϫ4 M PDBu eliminated it. Maximal tensions as percent K ϩ -induced tension at 10 Ϫ4 M NE for NE alone and in the presence of 10 Ϫ6 M Indo (n ϭ 3) were similar to those of PDBu.
We also examined the role of PKC inhibition on NE-induced increase in [Ca 2ϩ ] i and tension in adult and fetal cerebral arteries. For adult MCA, Fig. 4A shows the NE-induced tension increase in the presence of NE alone and 10 Ϫ8 or 10 Ϫ7 M Sta. The markedly enhanced sensitivity is apparent, i.e., shift to the left of the dose-response curve. The pD 2 value in the presence of 10 Ϫ7 or 10 Ϫ6 M Sta was 5.9 Ϯ 0.1 for each compared with the control value of 5.5 Ϯ 0.1 (n ϭ 3). Maximal NE-induced tensions of adult MCA in the presence of Sta were 120 Ϯ 5 and 98 Ϯ 22% compared with the control value of 91 Ϯ 7%. Figure 4B shows the adult MCA fluorescence ratio in response to NE alone and in the presence of 10 Ϫ8 or 10 Ϫ7 M Sta. In the presence of Sta, the sensitivity of the NE-induced fluorescence ratio was increased, with pD 2 values of 6.6 Ϯ 0.1 and 6.3 Ϯ 0.1 for 10 Ϫ7 or 10 Ϫ8 M, respectively, compared with the control value of 5.8 Ϯ 0.1. The NE-induced responses in the presence of 10 Ϫ7 M Cal (n ϭ 3) were not significantly different from those of Sta.
For fetal MCA, Fig. 4C illustrates the NE-induced tension in the presence of NE alone and 10 Ϫ8 or 10 Ϫ7 M Sta. In contrast to responses in the adult, in fetal MCA, 10 Ϫ8 M Sta resulted in attenuated NE-induced tension to ϳ40% K max with no shift of the dose-response curve (n ϭ 5). Pretreatment with 10 Ϫ7 M Sta (n ϭ 3) resulted in essentially no increase in tension in response to NE (Fig. 4C) . Figure 4D shows the fetal MCA fluorescence ratio in response to NE with attenuated response in the presence of 10 Ϫ8 or 10 Ϫ7 M Sta. In the presence of 10 Ϫ8 M Sta, the maximal F 340/380 was decreased to 38% K max . Again, with 10 Ϫ7 M Sta, there was no NEinduced increase in fluorescence ratio.
PKC-induced contractions. To explore the role of PKC activation per se in increasing cerebral artery tone, we examined contractile responses in cerebral arteries to both PDBu and Indo. In response to 10 Ϫ5 M PDBu, adult MCA tension increased to peak at ϳ120 s. In contrast, the fluorescence ratio did not change significantly. Figure 5A summarizes the dose-response relationship in adult MCA for 10 Ϫ8 to 10 Ϫ4 M PDBu of both tension and fluorescence ratio as percent K max (n ϭ 4). The role of PDBu in increasing Ca 2ϩ sensitivity is evident with the significantly increased tension to ϳ65% K max (pD 2 ϭ 6.0 Ϯ 0.1) with essentially no change in fluorescence ratio. In response to increasing doses of Indo, tension also increased similarly to ϳ50% K max with no increase in [Ca 2ϩ ] i . Also, after 20 min exposure to 10 Ϫ5 M PDBu, neither vascular tension nor F 340/380 increased in response to increasing doses of NE (10 Ϫ9 to 10 Ϫ4 M). Again, after ϳ20 min steady-state Indo, in response to increasing doses of NE (10 Ϫ9 to 10 Ϫ4 M), neither vascular tension nor fluorescence ratio increased significantly.
We also explored the role of PKC activation on fetal cerebral artery tension and [Ca 2ϩ ] i . Fetal MCA responded to 10 Ϫ5 M PDBu with an increase in vascular tension similar to that seen with NE. In contrast to the adult cerebral artery, however, in the fetus, the [Ca 2ϩ ] i also increased significantly. Figure 5C summarizes M) failed to increase either vascular tension or fluorescence ratio.
To examine the role of extracellular Ca 2ϩ in PDBustimulated tone, we repeated these studies in the presence of zero [Ca 2ϩ ] o . As shown in Fig. 5B , for the adult MCA, when [Ca 2ϩ ] o ϭ 0, the responses of tension and fluorescence ratio (n ϭ 4) were not significantly different from those seen in the presence of 1.8 mM [Ca 2ϩ ] o (Fig. 5A) . In contrast, in the fetal MCA, the PDBustimulated responses in the presence of zero [Ca 2ϩ ] o for 2 min, differed markedly from those in normal Krebs buffer. With [Ca 2ϩ ] o equal to zero, the fetal MCA showed no response of either tension or fluorescence ratio ( Fig. 5D; n ϭ 4) .
DISCUSSION
The present studies offer several important observations in relation to PKC in cerebral arteries, its role in NE-mediated contraction, and the extent to which this function differs in the fetus compared with the adult. In several respects, the role of PKC in fetal and adult cerebral arteries appears similar, namely in regards to both total PKC and its activity, the increase in PKC activity in response to stimulation by phorbol ester (Table 1) , the corresponding decrease in Ins(1,4,5)P 3 ( Fig. 2) , as well as tension and [Ca 2ϩ ] i (Fig. 3) , in response to PKC activation, and PDBu-mediated increase in tension (Fig. 5) . In contrast, in other respects, PKC showed significant differences between fetal and adult cerebral arteries, e.g., the several PKC isoenzymes and their relative abundance differed (Fig. 1) ; with Sta-induced PKC inhibition, fetal cerebral arteries showed no NE-mediated Ins(1,4,5)P 3 increase over that seen with NE alone (Fig. 2B) , whereas in adult arteries, the Ins(1,4,5)P 3 response was markedly augmented with a significant increase in pD 2 ( Fig. 2A) . Also, in fetal MCA, PKC inhibition resulted in profound inhibition of both tension and [Ca 2ϩ ] i in response to NE (Fig. 4, C and D) compared with the adult MCA, which showed markedly increased sensitivity (e.g., increase in pD 2 ; Fig. 4, A and B) . In addition, in adult cerebral arteries, PDBu-induced PKC stimulation significantly increased Ca 2ϩ sensitivity (Fig. 5A) , whereas in the fetal artery, although PKC stimulation by PDBu also increased Ca 2ϩ sensitivity somewhat, this was accompanied by a significant increase in [Ca 2ϩ ] i (Fig.  5C ). Finally, although adult cerebral arteries responded to PKC stimulation in the absence of [Ca 2ϩ ] o (Fig. 5B) , arteries of the fetus did not (Fig. 5D) .
These results in fetal and adult cerebral arteries are the first to demonstrate the dual role of PKC in modulating the responses of Ins(1,4,5)P 3 , [Ca 2ϩ ] i , and tension. For fetal vessels, the data suggest that PKC is more closely linked with modulating Ca 2ϩ flux via plasma membrane Ca 2ϩ channels and perhaps by other non-Ins(1,4,5)P 3 -related events. The studies also suggest that PKC and its several isoforms play a key role in the regulation of tone in these vessels.
PKC and vascular contraction. PKC, a phospholipiddependent serine/threonine protein kinase, is present in essentially all animal cells including vascular smooth muscle (18, 29) . Molecular cloning and biochemical analysis have shown that the PKC family includes at least 11 isoforms, representing 10 separate ] i responses to NE under control conditions and in the presence of PKC inhibition by staurosporine. Arterial segments were first contracted with 120 mM K ϩ to obtain peak tension. After washing and reequilibration to baseline tension, we induced subsequent contractions using cumulative doses of NE added in half-log increments. A: adult MCA vascular tensions (in g) as %K max , diacylglycerol, and phosphatidylserine (PS), a membrane phospholipid. "Novel," "new," or "group B" PKCs (␦, ⑀, , and ) are activated by DAG but are Ca 2ϩ independent, whereas "atypical" PKCs ( and ) require neither Ca 2ϩ nor DAG for activation but are activated by PS (37, 38) . The isoforms PKC-␣, -␤ I , -␤ II , -␦, -⑀, and -have been reported in vascular smooth muscle (14, 25, 37) ; however, their role in modulating contraction is not well defined. In general, PKC activation has been shown to be associated with its translocation from the cytoplasm to the plasma membrane (11, 29) . DAG binding to the PKC regulatory domain (C 1 region) dramatically increases Ca 2ϩ affinity and enzyme activity. PKC isoforms have been shown to differ considerably among different tissues (37) . We know of only several other studies of PKC and/or isoform changes with development. PKC-␤ II expression is prominent in rat kidney glomerulus on postnatal days 1-5, but not thereafter, and appears to be associated with the immature glomerulus (36) . In the rat pituitary, PKC-␦ decreased as PKC-⑀ increased with developmental age (6 days to 3 mo), whereas in whole brain, PKC-␦ increased as PKC-decreased (8 (10) . In contrast, the PKC-mediated pathway is believed to predominate during the prolonged tonic phase of agonist-induced contractions and may occur in the presence of relatively low [Ca 2ϩ ] i (35) and sustained phospholipid hydrolysis. PKC activation is believed to phosphorylate a myofilament regulatory protein in the mitogen-activated kinase (19, 20) or, by other mechanisms, increase Ca 2ϩ sensitivity and contraction via ras p21 and related small G proteins (3) The dual effect of PKC on vascular contractility is well documented. PKC negative feedback can inhibit Ins(1,4,5)P 3 synthesis, [Ca 2ϩ ] i release, and thus vascular tension (2, 6, 26) . In addition, a number of workers have demonstrated vascular contraction after PKC activation, which typically develops slowly, is sustained, and is [Ca 2ϩ ] i independent (1, 7, 11, 19, 33, 35) . Among its several isoforms, the Ca 2ϩ -independent isoform PKC-⑀ appears to play a key role in vascular contraction (21) by disinhibition of thin-filament myosin light chains (14, 38) and associated calponin and/or inhibition of myosin light chain dephosphorylation (25) . Thus the current findings of significantly lower PKC-⑀ levels in fetal cerebral arteries, compared with the adult, may be important in terms of their altered PKC-mediated function.
Although PKC has been quantified in brain, heart, and other tissues, there are relatively few studies in vascular smooth muscle (19, 20, 28) . We are unaware of quantitative PKC measurements or the determination of isoforms in cerebral arteries. The present results demonstrate an apparent paradox. On one hand, total PKC levels and activity were similar in fetal and adult cerebral arteries, as were agonist-induced increases in PKC activity (Table 1) . On the other hand, PKC stimulation and inhibition had widely differing effects in fetal and adult cerebral arteries. The significant differences in PKC function in the fetal and adult cerebral arteries probably reflect the differences in relative abundance of the several isoenzymes as well as other differences in the two age groups.
PKC modulation of Ins (1, 4, 5 )P 3 response to inhibit contraction. The present results demonstrate phorbol ester inhibition of NE-induced Ins(1,4,5)P 3 formation in cerebral arteries of both adult and fetus (Fig. 2) and agree with other studies. For instance, several investigators have demonstrated phorbol myristate acetate (PMA) dose-dependent suppression of NE-induced Ins(1,4,5)P 3 formation in rat aorta (2, 26) . In addition, our demonstration that PKC inhibition by Sta potentiates the NE-induced Ins(1,4,5)P 3 response in adult cerebral arteries (Fig. 2) has been shown for other vascular smooth muscle. For instance, in rat aorta, 10 Ϫ7 M Sta pretreatment increased NE-induced Ins(1,4,5)P 3 levels severalfold (2) and significantly inhibited PMA-induced contraction (5) The present studies illustrate further aspects of the role of PKC activation on inhibiting the contraction of MCAs in the fetus and adult (Fig. 3) ] i responses to NE (Fig. 3) with little difference in the response of the two age groups. The studies also demonstrate the contrasting effects of PKC inhibition by Sta on NE-induced contraction in adult and fetal MCAs. As is evident, in the adult, 10 Ϫ8 and 10 Ϫ7 M Sta resulted in markedly increased sensitivity to NE with increases in pD 2 values of both tension and [Ca 2ϩ ] i . In the fetus, however, Sta-induced inhibition of PKC had a strikingly different effect in the fetus with inhibition of NE-induced increase in tension and [Ca 2ϩ ] i (Fig. 4) ] i , although the mechanism of this effect is not clear (5, 35) . In rabbit (12) and rat (16) aortas, PKC activation may potentiate ␣ 1 -adrenergicinduced contraction by modulation of plasma membrane Ca 2ϩ -channel activity. In rat cerebral arteries, both PKC activation and inhibition modified basic myogenic tone and artery caliber (31) .
The present studies illustrate the manner in which PKC can increase Ca 2ϩ sensitivity in vascular smooth muscle, e.g., an increase in tone in the absence of a rise in [Ca 2ϩ ] i , particularly in the adult. Figure 5 illustrates this PKC-induced increase in Ca 2ϩ sensitivity of adult MCA. With 10 Ϫ5 M PDBu-induced contraction, there was essentially no change in [Ca 2ϩ ] i (Fig. 5A) . The PDBu-induced increase in Ca 2ϩ sensitivity is less evident in fetal cerebral arteries. In fact, as shown in ] i increase per increase in tension was not as great as that seen in response to NE or other agonists (22) . Because in fetal MCA (in contrast to that of the adult), the PDBu-induced increases in tension and [Ca 2ϩ ] i were abolished in the presence of zero [Ca 2ϩ ] o (Fig. 5D ), this implies a lack of Ca 2ϩ flux via plasma membrane Ca 2ϩ channels (22) . As noted, several studies in vascular smooth muscle cells support the idea that PKC can increase Ca 2ϩ flux via L-type, voltage-gated Ca 2ϩ channels and thus contraction, presumably by phosphorylation and increasing their probability of open state (13, 30) .
Perspectives
In cerebral arteries of the adult, PKC appears to function in the traditional manner, with PKC existing in dual regulating roles, e.g, a membrane-bound component that is receptor activated and exerts negative feedback on PLC and Ins(1,4,5)P 3 synthesis, and a second more general component that, on activation, increases Ca 2ϩ sensitivity and vascular contraction. In the adult vessel, inhibition of ␣ 1 -AR-coupled PKC decreases its negative feedback on PLC, thereby increasing sensitivity to NE and augmenting NE-induced Ins(1,4,5)P 3 responses. In the fetal cerebral artery, in contrast, perhaps because of relatively low PKC-⑀ levels, but also with other factors (differences in small GTPases, mitogen-activated protein kinases, tyrosine kinases, and so forth), PKC coupling to PLC and the ␣ 1 -AR is poor or nonexistent. Also, in the fetus, but not adult, these responses were eliminated in the presence of zero [Ca 2ϩ ] o . This latter finding, in concert with the Of interest in fetal CCA is that, whereas ␣ 1 -adrenergic stimulation failed to increase Ins(1,4,5)P 3 under control conditions, such stimulation elicited a robust Ins(1,4,5)P 3 response when PKC was inhibited. This supports the idea of tonic feedback inhibition by PKC in some fetal vessels.
During the course of development from fetus to newborn to adult, the cerebral blood vessels undergo striking changes in morphology as well as in pharmacomechanical and electromechanical coupling mechanisms. These changes are accompanied by changes in ␣ 1 -AR density and NE-induced Ins(1,4,5)P 3 responses (23, 24) , Ins(1,4,5)P 3 -receptor density (39) , and numerous other factors (22) including the presently observed differences in PKC levels, isoenzymes, and PKC-related mechanisms of contraction. On the basis of the present results, one may speculate that PKC activation by DAG or other agonists may be important in the modulation of pharmacomechanical coupling. PKC modulation of NE-induced cerebrovascular signal-transduction responses thus may play a key role in the regulation of cerebral blood flow under physiological conditions. Of potential importance, these PKC-mediated mechanisms, including the relative lack of PKC-⑀ and the abundance of other isoforms, may also play a role in conditions associated with dysregulation of cerebral blood flow in the fetus, newborn, and/or adult. The role of these mechanisms and their change with development are important avenues for future studies.
